PI3K/AKT signaling is elevated in a high proportion of PC patients due to the genetic alterations and deregulated gene expression of PI3K pathway components occurring in as many as 42% of primary and 100% of metastatic PC samples [38, 39, 40, 41, 42]. Here, AKT1 is linked to pachyonychia congenita.